Statins and other drugs: Facing COVID-19 as a vascular disease

Fabian Sanchis-Gomar; Carme Perez-Quilis; Emmanuel J Favaloro; Giuseppe Lippi

doi:10.1016/j.phrs.2020.105033

Statins and other drugs: Facing COVID-19 as a vascular disease

Fabian Sanchis-Gomar, Carme Perez-Quilis, Emmanuel J Favaloro, Giuseppe Lippi

Dentistry and Medical Sciences

Research output: Contribution to journal › Letter › peer-review

5 Citations (Scopus)

Original language	English
Article number	105033
Number of pages	1
Journal	Pharmacological Research
Volume	159
Early online date	17 Jun 2020
DOIs	https://doi.org/10.1016/j.phrs.2020.105033
Publication status	Published - Sept 2020

Access to Document

10.1016/j.phrs.2020.105033

Cite this

@article{7685fad86ed048598c241bb918bc86a3,

title = "Statins and other drugs: Facing COVID-19 as a vascular disease",

keywords = "Betacoronavirus, COVID-19, Coronavirus Infections, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Nursing Homes, Pandemics, Pneumonia, Viral, SARS-CoV-2, Vascular Diseases",

author = "Fabian Sanchis-Gomar and Carme Perez-Quilis and Favaloro, {Emmanuel J} and Giuseppe Lippi",

year = "2020",

month = sep,

doi = "10.1016/j.phrs.2020.105033",

language = "English",

volume = "159",

journal = "Pharmacological Research Communications",

issn = "1043-6618",

publisher = "Academic Press",

}

TY - JOUR

T1 - Statins and other drugs

T2 - Facing COVID-19 as a vascular disease

AU - Sanchis-Gomar, Fabian

AU - Perez-Quilis, Carme

AU - Favaloro, Emmanuel J

AU - Lippi, Giuseppe

PY - 2020/9

Y1 - 2020/9

KW - Betacoronavirus

KW - COVID-19

KW - Coronavirus Infections

KW - Humans

KW - Hydroxymethylglutaryl-CoA Reductase Inhibitors

KW - Nursing Homes

KW - Pandemics

KW - Pneumonia, Viral

KW - SARS-CoV-2

KW - Vascular Diseases

U2 - 10.1016/j.phrs.2020.105033

DO - 10.1016/j.phrs.2020.105033

M3 - Letter

C2 - 32562814

SN - 1043-6618

VL - 159

JO - Pharmacological Research Communications

JF - Pharmacological Research Communications

M1 - 105033

ER -